Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Luke Evnin sold 143,199 Werewolf Therapeutics, Inc. shares (Form 4)

Traded Jul 6 to Jul 7, 2026 · Filed Jul 8, 2026

From Jul 6 to Jul 7, 2026, Luke Evnin (Director) sold 143,199 Werewolf Therapeutics, Inc. shares at an average US$0.31 for US$44,749 under a trading plan, leaving 0 shares. Filed Jul 8, 2026 (Form 4).

Sold
143,199 shares
Price
US$0.31 average (US$0.31 to US$0.32)
Value
US$44,749
Holding after
0 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 6, 2026Common StockSale35,770US$0.32107,429Indirect
Jul 7, 2026Common StockSale107,429US$0.310Indirect

Source

View original at SEC

Related